|
Clinical Studies
Citations 331-340 of 355 total displayed.
|
Past content
(since Nov 2000):
|
- Images in Cardiovascular Medicine
Flash Pulmonary Edema Heralding Renal Artery Stenosis
- Shehzad Basaria and Herbert L. Fred
Circulation 2002;105:899, doi:10.1161/hc0802.101575
[Full text]
- Articles
Change in Diastolic Left
Ventricular Filling After One Year of Antihypertensive
Treatment. The Losartan Intervention For Endpoint
Reduction in Hypertension (LIFE) Study
- Kristian Wachtell, Jonathan N. Bella, Jens Rokkedal, Vittorio Palmieri, Vasilios Papademetriou, Björn Dahlöf, Tapio Aalto, Eva Gerdts, and Richard B. Devereux
Circulation published February 11, 2002, doi:10.1161/hc0902.104599
[Abstract]
- Clinical Investigations and Reports
Fosinopril Versus Amlodipine Comparative Treatments Study: A Randomized Trial to Assess Effects on Plasminogen Activator Inhibitor-1
- Marco Pahor, Lonneke V. Franse, Steven R. Deitcher, William C. Cushman, Karen C. Johnson, Ronald I. Shorr, Kandice Kottke-Marchant, Russell P. Tracy, Grant W. Somes, and William B. Applegate
Circulation 2002;105:457-461, doi:10.1161/hc0402.102929
[Abstract]
[Full text]
- Articles
Peroxisome Proliferator--Activated
Receptor  Gene Regulates Left Ventricular Growth in
Response to Exercise and Hypertension
- Yalda Jamshidi, Hugh E. Montgomery, Hans-Werner Hense, Saul G. Myerson, Ines Pineda Torra, Bart Staels, Michael J. World, Angela Doering, Jeanette Erdmann, Christian Hengstenberg, Steve E. Humphries, Heribert Schunkert, and David M. Flavell
Circulation published January 22, 2002, doi:10.1161/hc0802.104535
[Abstract]
- Articles
Peroxisome Proliferator--Activated
Receptor Gene Regulates Left Ventricular Growth in
Response to Exercise and Hypertension
- Yalda Jamshidi, Hugh E. Montgomery, Hans-Werner Hense, Saul G. Myerson, Ines Pineda Torra, Bart Staels, Michael J. World, Angela Doering, Jeanette Erdmann, Christian Hengstenberg, Steve E. Humphries, Heribert Schunkert, and David M. Flavell
Circulation published January 22, 2002, doi:10.1161/hc0802.104535
[Abstract]
- Correspondence
Does Reduced Vascular Stiffening Fully Explain Preserved Cardiovagal Baroreflex Function in Older Physically Active Men? • Response
- Michael F. O’Rourke, Wilmer W. Nichols, Brian E. Hunt, William B. Farquhar, and J. Andrew Taylor
Circulation 2002;105:e11
[Full text]
- Clinical Investigations and Reports
Association Between SAH, an Acyl-CoA Synthetase Gene, and Hypertriglyceridemia, Obesity, and Hypertension
- Naoharu Iwai, Tomohiro Katsuya, Toshifumi Mannami, Jitsuo Higaki, Toshio Ogihara, Koichi Kokame, Jun Ogata, and Shunroku Baba
Circulation 2002;105:41-47, doi:10.1161/hc0102.101780
[Abstract]
[Full text]
- Clinical Investigations and Reports
Antecedent Blood Pressure and Risk of Cardiovascular Disease: The Framingham Heart Study
- Ramachandran S. Vasan, Joseph M. Massaro, Peter W.F. Wilson, Sudha Seshadri, Philip A. Wolf, Daniel Levy, and Ralph B. D’Agostino
Circulation 2002;105:48-53, doi:10.1161/hc0102.101774
[Abstract]
[Full text]
- Correspondence
Angiotensin II Type 1 Receptor Blockers and Congestive Heart Failure • Response
- Johann W. Auer, Robert Berent, Bernd Eber, and Michel Burnier
Circulation 2001;104:e82
[Full text]
- Clinical Investigations and Reports
Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
- David A. Kass, Edward P. Shapiro, Miho Kawaguchi, Anne R. Capriotti, Angelo Scuteri, Robert C. deGroof, and Edward G. Lakatta
Circulation 2001;104:1464-1470; published online before print as doi:10.1161/hc3801.097806
[Abstract]
[Full text]
|
|
